Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
120.2 USD | +2.40% | -0.75% | -13.64% |
Apr. 22 | Bernstein Adjusts Price Target on Illumina to $129 From $150 | MT |
Apr. 22 | Baird Adjusts Price Target on Illumina to $125 From $146, Neutral Rating Kept | MT |
Evolution of the average Target Price on Illumina, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Illumina, Inc.
Baptista Research | |
Leerink Partners | |
RBC Capital Markets | |
OTR Global | |
UBS | |
TD Cowen | |
Barclays | |
Citigroup | |
Stifel Nicolaus | |
Baird | |
Scotiabank | |
Stephens Inc. | |
BofA Securities | |
Canaccord Genuity | |
Bernstein | |
Piper Sandler | |
HSBC | |
JPMorgan Chase | |
Evercore ISI | |
Credit Suisse | |
SVB Securities LLC | |
Argus | |
Morgan Stanley | |
Cowen | |
SVB Leerink | |
BTIG | |
Wells Fargo Securities | |
Atlantic Equities |
EPS Revisions
- Stock Market
- Equities
- ILMN Stock
- Consensus Illumina, Inc.